Centralized repository of statutory submissions, regulatory correspondence, and compliance documentation across all Aevum Zenth subsidiaries and operating divisions.
| Filing ID | Date Filed | Division | Jurisdiction | Document Type | Status | Actions |
|---|---|---|---|---|---|---|
| AZC-2024-SEC-10K | 2025-02-14 | Capital Group | SEC / USA | Annual Report (10-K) | Filed & Active | |
| AZC-2025-ESMA-NRC-442 | 2025-03-10 | Energy & Power | ESMA / EU | Regulatory Notice | Under Review | |
| AZC-2025-FCA-COS-889 | 2025-01-22 | Aerospace & Defense | CAA / UK | Operational License Renewal | Filed & Active | |
| AZC-2024-FDA-IND-112 | 2025-04-05 | Health Sciences | FDA / USA | Investigational New Drug (Amend) | Amended | |
| AZC-2025-SG-MC-301 | 2025-03-28 | Global Logistics | ACRA / SG | Quarterly Compliance Report | Filed & Active | |
| AZC-2025-EU-AI-773 | 2025-02-18 | Digital Systems | EU Commission | AI Act High-Risk Classification | Withdrawn | |
| AZC-2024-EPA-RPT-990 | 2025-01-15 | Energy & Power | EPA / USA | Environmental Compliance Annual | Filed & Active | |
| AZC-2025-FCA-QTR-221 | 2025-04-12 | Capital Group | FCA / UK | Quarterly Capital Adequacy | Under Review |
All filings displayed on this portal are official records submitted to relevant governmental and regulatory authorities. Documents are indexed by filing date, subsidiary entity, and jurisdictional requirement.
Access to restricted or embargoed filings requires prior authorization through the Aevum Zenth Legal & Compliance Office. Unauthorized distribution, reproduction, or reverse engineering of regulatory submissions is strictly prohibited and may violate securities, privacy, and intellectual property statutes.
For regulatory inquiries, whistleblower submissions, or subpoena responses, contact compliance@aevumzenth.com or reference our Ethics & Whistleblower Policy.